{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T06:08:16Z","timestamp":1780380496746,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.leukres.2018.11.018","type":"journal-article","created":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T13:03:09Z","timestamp":1544014989000},"page":"48-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Comparison of 18F FDG PET-CT AND CECT in pretreatment staging of adults with Hodgkin\u2019s lymphoma"],"prefix":"10.1016","volume":"76","author":[{"given":"Martina","family":"Panebianco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oreste","family":"Bagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Cenfra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Mecarocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elettra","family":"Ortu La Barbera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Filippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Codacci-Pisanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Biondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Laghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Cimino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2018.11.018_bib0005","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3324\/haematol.2013.103218","article-title":"The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale","volume":"99","author":"Gallamini","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2018.11.018_bib0010","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw249","article-title":"Hodgkin lymphoma: current status and clinical trial recommendations","volume":"109","author":"Diefenbach","year":"2017","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.leukres.2018.11.018_bib0015","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1182\/asheducation.V2012.1.322.3800161","article-title":"How does PET\/CT help in selecting therapy for patients with Hodgkin lymphoma?","author":"Hutchings","year":"2012","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.leukres.2018.11.018_bib0020","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2018.11.018_bib0025","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/annonc\/mdx097","article-title":"International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)","volume":"28","author":"Younes","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.leukres.2018.11.018_bib0030","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1023\/A:1008486928190","article-title":"Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin\u2019s disease","volume":"9","author":"Bangerter","year":"1998","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.leukres.2018.11.018_bib0035","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1023\/A:1008368330519","article-title":"2-Fluorine-18-fluoro-2-deoxy-D glucose positron emission tomography in the pretreatment staging of Hodgkin's disease: influence on patient management in a single institution","volume":"11","author":"Partridge","year":"2000","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.leukres.2018.11.018_bib0040","first-page":"266","article-title":"Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin\u2019s disease","volume":"86","author":"Jerusalem","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2018.11.018_bib0045","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00277-001-0390-y","article-title":"Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin\u2019s disease","volume":"81","author":"Weihrauch","year":"2002","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.leukres.2018.11.018_bib0050","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1093\/annonc\/mdh426","article-title":"Contribution of PET imaging to the initial staging and prognosis of patients with Hodgkin\u2019s disease","volume":"15","author":"Munker","year":"2004","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.leukres.2018.11.018_bib0055","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/sj.bjc.6601561","article-title":"Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin\u2019s lymphoma","volume":"90","author":"Naumann","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.leukres.2018.11.018_bib0060","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00259-005-0019-9","article-title":"Comparison of 18F-FDG-PET and standard procedures for the pretreatment staging of children and adolescents with Hodgkin\u2019s disease","volume":"33","author":"Kabickova","year":"2006","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.leukres.2018.11.018_bib0065","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00277-007-0356-9","article-title":"Intergruppo Italiano Linfomi, Positron emission tomography in the staging of patients with Hodgkin\u2019s lymphoma. A prospective multicentric study by the Intergruppo Italiano Linfomi","volume":"86","author":"Rigacci","year":"2007","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.leukres.2018.11.018_bib0070","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/1097-0142(20010301)91:5<889::AID-CNCR1078>3.0.CO;2-5","article-title":"2-(Fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial","volume":"91","author":"Buchmann","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2018.11.018_bib0075","first-page":"567","article-title":"Diagnostic value of CT, PET and combined PET\/CT performed with low-dose unenhanced CT and full-dose enhanced CT in the initial staging of lymphoma","volume":"55","author":"Pinilla","year":"2011","journal-title":"Q. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.leukres.2018.11.018_bib0080","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0002-9343(01)01117-2","article-title":"Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphoma","volume":"112","author":"Wirth","year":"2002","journal-title":"Am. J. Med."},{"key":"10.1016\/j.leukres.2018.11.018_bib0085","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/annonc\/mdj024","article-title":"Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET\/CT era?","volume":"17","author":"Raanani","year":"2006","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.leukres.2018.11.018_bib0090","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1093\/annonc\/mdn282","article-title":"Combined PET and low-dose, noncontrast CT scanning obviates the need for additional diagnostic contrast-enhanced CT scans in patients undergoing staging or restaging for lymphoma","volume":"19","author":"Elstrom","year":"2008","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.leukres.2018.11.018_bib0095","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s11547-008-0264-7","article-title":"Role of whole-body [18F] fluorodeoxyglucose positron emission tomography\/computed tomography (FDG-PET\/CT) and conventional techniques in the staging of patients with Hodgkin and aggressive non Hodgkin lymphoma","volume":"113","author":"Pelosi","year":"2008","journal-title":"Radiol. Med."},{"key":"10.1016\/j.leukres.2018.11.018_bib0100","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.3109\/10428194.2014.900761","article-title":"Clinical impact of contrast-enhanced computed tomography combined with low-dose (18)F-fluorodeoxyglucose positron emission tomography\/computed tomography on routine lymphoma patient management","volume":"55","author":"Chalaye","year":"2014","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.leukres.2018.11.018_bib0105","first-page":"5727","article-title":"The significance of PET\/CT in the initial staging of hodgkin lymphoma: experience outside clinical trials","volume":"37","author":"Angelopoulou","year":"2017","journal-title":"Anticancer Res."},{"key":"10.1016\/j.leukres.2018.11.018_bib0110","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1182\/blood-2015-11-679407","article-title":"PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study","volume":"127","author":"Barrington","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2018.11.018_bib0115","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/10428194.2014.919635","article-title":"Comparison of positron emission tomography\/computed tomography with classical contrast-enhanced computed tomography in the initial staging of Hodgkin lymphoma","volume":"56","author":"Bednaruk-M\u0142y\u0144ski","year":"2015","journal-title":"Leuk. Lymphoma"},{"issue":"Suppl 3","key":"10.1016\/j.leukres.2018.11.018_bib0120","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/annonc\/mdu181","article-title":"ESMO guidelines working group, Hodgkin\u2019s lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"25","author":"Eichenauer","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.leukres.2018.11.018_bib0125","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/bjh.14071","article-title":"(18) F-FDG PET-CT and trephine biopsy assessment of bone marrow involvement in lymphoma","volume":"174","author":"Ujjani","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2018.11.018_bib0130","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1600-0609.2005.00467.x","article-title":"EORTC Lymphoma Group, the EORTC strategy in the treatment of Hodgkin\u2019s lymphoma","volume":"66","author":"Eghbali","year":"2005","journal-title":"Eur. J. Haematol. Suppl."},{"key":"10.1016\/j.leukres.2018.11.018_bib0135","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","article-title":"A prognostic score for advanced Hodgkin\u2019s disease. International prognostic factors project on advanced hodgkin\u2019s disease","volume":"339","author":"Hasenclever","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.leukres.2018.11.018_bib0140","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"European Association of Nuclear Medicine (EANM), FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0","volume":"42","author":"Boellaard","year":"2015","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.leukres.2018.11.018_bib0145","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","article-title":"Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin\u2019s disease: cotswolds meeting","volume":"7","author":"Lister","year":"1989","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2018.11.018_bib0150","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.ijrobp.2014.04.026","article-title":"Role of FDG-PET in the implementation of involved-node radiation therapy for Hodgkin lymphoma patients","volume":"89","author":"Girinsky","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212618304879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212618304879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T15:39:01Z","timestamp":1573054741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212618304879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":30,"alternative-id":["S0145212618304879"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2018.11.018","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of 18F FDG PET-CT AND CECT in pretreatment staging of adults with Hodgkin\u2019s lymphoma","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2018.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}